Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$15.78 - $24.77 $1.04 Million - $1.63 Million
-65,900 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$25.02 - $54.99 $525,420 - $1.15 Million
21,000 Added 46.77%
65,900 $1.7 Million
Q2 2020

Aug 13, 2020

BUY
$39.26 - $52.73 $113,854 - $152,917
2,900 Added 6.9%
44,900 $2.18 Million
Q1 2020

May 14, 2020

BUY
$31.65 - $46.87 $63,300 - $93,740
2,000 Added 5.0%
42,000 $1.78 Million
Q4 2019

Feb 14, 2020

SELL
$36.21 - $51.4 $1.82 Million - $2.59 Million
-50,400 Reduced 55.75%
40,000 $1.71 Million
Q3 2019

Nov 14, 2019

SELL
$22.22 - $44.01 $297,748 - $589,734
-13,400 Reduced 12.91%
90,400 $3.25 Million
Q1 2019

May 15, 2019

BUY
$16.17 - $27.38 $129,360 - $219,040
8,000 Added 8.35%
103,800 $2.79 Million
Q4 2018

Feb 12, 2019

BUY
$14.32 - $22.92 $555,616 - $889,296
38,800 Added 68.07%
95,800 $1.55 Million
Q3 2018

Nov 13, 2018

BUY
$13.03 - $21.81 $742,710 - $1.24 Million
57,000 New
57,000 $1.18 Million
Q2 2018

Aug 07, 2018

SELL
$15.07 - $22.34 $520,668 - $771,847
-34,550 Closed
0 $0
Q1 2018

May 09, 2018

SELL
$22.47 - $32.33 $11,235 - $16,165
-500 Reduced 1.43%
34,550 $776,000
Q4 2017

Feb 14, 2018

SELL
$26.84 - $39.14 $2.2 Million - $3.21 Million
-81,950 Reduced 70.04%
35,050 $1.06 Million
Q3 2017

Nov 13, 2017

SELL
$29.49 - $38.37 $2.03 Million - $2.65 Million
-69,000 Reduced 37.1%
117,000 $4.41 Million
Q2 2017

Aug 14, 2017

BUY
N/A
186,000
186,000 $5.85 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.